Ultrasound Use for Difficult Lumbar Punctures in Pediatric Oncology Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hematology-oncology patients may require frequent lumbar puncture for diagnosis, assessment and therapy. When LP is difficult, the patient may endure multiple attempts, prolonged anesthesia time, and with failure of LP may require fluoroscopy-guidance with associated radiation exposure. This investigation will evaluate lumbar punctures performed in the intraoperative setting by oncologists with ultrasound guidance performed by the anesthesiologist in the leukemic pediatric population. The investigators hypothesis is that anesthesiologist guided ultrasound assistance will decrease intraoperative time, number of attempts and need to have the procedure done with fluoroscopy minimizing radiation exposure.
| Condition | Intervention |
|---|---|
|
Leukemia |
Procedure: Ultrasound |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Ultrasound Imaging Facilitates Lumbar Punctures in Pediatric Oncology Patients With Difficult Surface Landmarks and/or a History of Difficult Lumbar Puncture |
- Number of punctures [ Time Frame: 1 day ] [ Designated as safety issue: No ]Number of punctures required to obtain cerebral spinal fluid.
| Estimated Enrollment: | 50 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Ultrasound |
Procedure: Ultrasound
Ultrasound guidance for difficult lumbar punctures in the leukemic pediatric population.
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All patients undergoing LP as per Heme-Onc clinic who have been deemed to be difficult LP placements.
Exclusion Criteria:
- Patients having concomitant procedures (bone marrow bx, etc.)
Contacts and Locations
More Information
Publications:
| Responsible Party: | Tarun Bhalla, MD, Assistant Professor, Nationwide Children's Hospital |
| ClinicalTrials.gov Identifier: | NCT01643291 History of Changes |
| Other Study ID Numbers: | IRB12-00335 |
| Study First Received: | July 12, 2012 |
| Last Updated: | July 16, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Leukemia Neoplasms by Histologic Type Neoplasms |
ClinicalTrials.gov processed this record on June 18, 2013